Global Point-of-Care Testing (POCT) Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

    North America is the largest sales place, with a sales market share nearly 47% in 2019. Following North America, Europe is the second largest sales place with the sales market share of 30%.

    Point-of-Care Testing (POCT) market report explains the definition, types, applications, major countries, and major players of the Point-of-Care Testing (POCT) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Ascensia

    • Bio-Rad Laboratories

    • Siemens Healthcare

    • Danaher

    • Quidel

    • Nova Biomedical

    • Johnson & Johnson

    • Abaxis (Zoetis)

    • Helena Laboratories

    • Ortho Clinical Diagnostics

    • Phamatech

    • BioMerieux

    • OraSure Technologies

    • Alfa Wassermann

    • ARKRAY

    • A Menarini Diagnostics

    • ELITech Group

    • Trinity Biotech

    • Chembio Diagnostics

    • Princeton BioMeditech

    • Trividia Health

    • Roche

    • Abbott

    • Response Biomedical

    • Accriva

    By Type:

    • Blood Glucose Testing

    • Infectious Diseases Testing

    • Cardiac Markers Testing

    • Coagulation Testing

    • Pregnancy and Fertility Testing

    • Blood Gas/Electrolytes Testing

    • Urinalysis Testing

    • Others

    By End-User:

    • Clinics

    • Hospitals

    • Laboratory

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Point-of-Care Testing (POCT) Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Point-of-Care Testing (POCT) Outlook to 2028- Original Forecasts

    • 2.2 Point-of-Care Testing (POCT) Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Point-of-Care Testing (POCT) Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Point-of-Care Testing (POCT) Market- Recent Developments

    • 6.1 Point-of-Care Testing (POCT) Market News and Developments

    • 6.2 Point-of-Care Testing (POCT) Market Deals Landscape

    7 Point-of-Care Testing (POCT) Raw Materials and Cost Structure Analysis

    • 7.1 Point-of-Care Testing (POCT) Key Raw Materials

    • 7.2 Point-of-Care Testing (POCT) Price Trend of Key Raw Materials

    • 7.3 Point-of-Care Testing (POCT) Key Suppliers of Raw Materials

    • 7.4 Point-of-Care Testing (POCT) Market Concentration Rate of Raw Materials

    • 7.5 Point-of-Care Testing (POCT) Cost Structure Analysis

      • 7.5.1 Point-of-Care Testing (POCT) Raw Materials Analysis

      • 7.5.2 Point-of-Care Testing (POCT) Labor Cost Analysis

      • 7.5.3 Point-of-Care Testing (POCT) Manufacturing Expenses Analysis

    8 Global Point-of-Care Testing (POCT) Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Point-of-Care Testing (POCT) Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Point-of-Care Testing (POCT) Export by Region (Top 10 Countries) (2017-2028)

    9 Global Point-of-Care Testing (POCT) Market Outlook by Types and Applications to 2022

    • 9.1 Global Point-of-Care Testing (POCT) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Blood Glucose Testing Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Infectious Diseases Testing Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Cardiac Markers Testing Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Coagulation Testing Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Pregnancy and Fertility Testing Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Blood Gas/Electrolytes Testing Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Urinalysis Testing Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Point-of-Care Testing (POCT) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Laboratory Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Point-of-Care Testing (POCT) Market Analysis and Outlook till 2022

    • 10.1 Global Point-of-Care Testing (POCT) Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.2.2 Canada Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.2.3 Mexico Point-of-Care Testing (POCT) Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.3.2 UK Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.3.3 Spain Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.3.4 Belgium Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.3.5 France Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.3.6 Italy Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.3.7 Denmark Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.3.8 Finland Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.3.9 Norway Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.3.10 Sweden Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.3.11 Poland Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.3.12 Russia Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.3.13 Turkey Point-of-Care Testing (POCT) Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.4.2 Japan Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.4.3 India Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.4.4 South Korea Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.4.5 Pakistan Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.4.6 Bangladesh Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.4.7 Indonesia Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.4.8 Thailand Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.4.9 Singapore Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.4.10 Malaysia Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.4.11 Philippines Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.4.12 Vietnam Point-of-Care Testing (POCT) Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.5.2 Colombia Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.5.3 Chile Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.5.4 Argentina Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.5.5 Venezuela Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.5.6 Peru Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.5.7 Puerto Rico Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.5.8 Ecuador Point-of-Care Testing (POCT) Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.6.2 Kuwait Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.6.3 Oman Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.6.4 Qatar Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Point-of-Care Testing (POCT) Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.7.2 South Africa Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.7.3 Egypt Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.7.4 Algeria Point-of-Care Testing (POCT) Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Point-of-Care Testing (POCT) Consumption (2017-2022)

      • 10.8.2 New Zealand Point-of-Care Testing (POCT) Consumption (2017-2022)

    11 Global Point-of-Care Testing (POCT) Competitive Analysis

    • 11.1 Ascensia

      • 11.1.1 Ascensia Company Details

      • 11.1.2 Ascensia Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Ascensia Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.1.4 Ascensia Point-of-Care Testing (POCT) Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Bio-Rad Laboratories

      • 11.2.1 Bio-Rad Laboratories Company Details

      • 11.2.2 Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Bio-Rad Laboratories Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.2.4 Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Siemens Healthcare

      • 11.3.1 Siemens Healthcare Company Details

      • 11.3.2 Siemens Healthcare Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Siemens Healthcare Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.3.4 Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Danaher

      • 11.4.1 Danaher Company Details

      • 11.4.2 Danaher Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Danaher Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.4.4 Danaher Point-of-Care Testing (POCT) Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Quidel

      • 11.5.1 Quidel Company Details

      • 11.5.2 Quidel Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Quidel Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.5.4 Quidel Point-of-Care Testing (POCT) Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Nova Biomedical

      • 11.6.1 Nova Biomedical Company Details

      • 11.6.2 Nova Biomedical Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Nova Biomedical Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.6.4 Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Johnson & Johnson

      • 11.7.1 Johnson & Johnson Company Details

      • 11.7.2 Johnson & Johnson Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Johnson & Johnson Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.7.4 Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Abaxis (Zoetis)

      • 11.8.1 Abaxis (Zoetis) Company Details

      • 11.8.2 Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Abaxis (Zoetis) Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.8.4 Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Helena Laboratories

      • 11.9.1 Helena Laboratories Company Details

      • 11.9.2 Helena Laboratories Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Helena Laboratories Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.9.4 Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Ortho Clinical Diagnostics

      • 11.10.1 Ortho Clinical Diagnostics Company Details

      • 11.10.2 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.10.4 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Phamatech

      • 11.11.1 Phamatech Company Details

      • 11.11.2 Phamatech Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Phamatech Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.11.4 Phamatech Point-of-Care Testing (POCT) Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 BioMerieux

      • 11.12.1 BioMerieux Company Details

      • 11.12.2 BioMerieux Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 BioMerieux Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.12.4 BioMerieux Point-of-Care Testing (POCT) Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 OraSure Technologies

      • 11.13.1 OraSure Technologies Company Details

      • 11.13.2 OraSure Technologies Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 OraSure Technologies Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.13.4 OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Alfa Wassermann

      • 11.14.1 Alfa Wassermann Company Details

      • 11.14.2 Alfa Wassermann Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Alfa Wassermann Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.14.4 Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 ARKRAY

      • 11.15.1 ARKRAY Company Details

      • 11.15.2 ARKRAY Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 ARKRAY Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.15.4 ARKRAY Point-of-Care Testing (POCT) Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 A Menarini Diagnostics

      • 11.16.1 A Menarini Diagnostics Company Details

      • 11.16.2 A Menarini Diagnostics Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 A Menarini Diagnostics Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.16.4 A Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    • 11.17 ELITech Group

      • 11.17.1 ELITech Group Company Details

      • 11.17.2 ELITech Group Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.17.3 ELITech Group Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.17.4 ELITech Group Point-of-Care Testing (POCT) Product Portfolio

      • 11.17.5 Recent Research and Development Strategies

    • 11.18 Trinity Biotech

      • 11.18.1 Trinity Biotech Company Details

      • 11.18.2 Trinity Biotech Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.18.3 Trinity Biotech Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.18.4 Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio

      • 11.18.5 Recent Research and Development Strategies

    • 11.19 Chembio Diagnostics

      • 11.19.1 Chembio Diagnostics Company Details

      • 11.19.2 Chembio Diagnostics Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.19.3 Chembio Diagnostics Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.19.4 Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio

      • 11.19.5 Recent Research and Development Strategies

    • 11.20 Princeton BioMeditech

      • 11.20.1 Princeton BioMeditech Company Details

      • 11.20.2 Princeton BioMeditech Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.20.3 Princeton BioMeditech Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.20.4 Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio

      • 11.20.5 Recent Research and Development Strategies

    • 11.21 Trividia Health

      • 11.21.1 Trividia Health Company Details

      • 11.21.2 Trividia Health Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.21.3 Trividia Health Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.21.4 Trividia Health Point-of-Care Testing (POCT) Product Portfolio

      • 11.21.5 Recent Research and Development Strategies

    • 11.22 Roche

      • 11.22.1 Roche Company Details

      • 11.22.2 Roche Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.22.3 Roche Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.22.4 Roche Point-of-Care Testing (POCT) Product Portfolio

      • 11.22.5 Recent Research and Development Strategies

    • 11.23 Abbott

      • 11.23.1 Abbott Company Details

      • 11.23.2 Abbott Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.23.3 Abbott Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.23.4 Abbott Point-of-Care Testing (POCT) Product Portfolio

      • 11.23.5 Recent Research and Development Strategies

    • 11.24 Response Biomedical

      • 11.24.1 Response Biomedical Company Details

      • 11.24.2 Response Biomedical Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.24.3 Response Biomedical Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.24.4 Response Biomedical Point-of-Care Testing (POCT) Product Portfolio

      • 11.24.5 Recent Research and Development Strategies

    • 11.25 Accriva

      • 11.25.1 Accriva Company Details

      • 11.25.2 Accriva Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.25.3 Accriva Point-of-Care Testing (POCT) Main Business and Markets Served

      • 11.25.4 Accriva Point-of-Care Testing (POCT) Product Portfolio

      • 11.25.5 Recent Research and Development Strategies

    12 Global Point-of-Care Testing (POCT) Market Outlook by Types and Applications to 2028

    • 12.1 Global Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Blood Glucose Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Infectious Diseases Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Cardiac Markers Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Coagulation Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Pregnancy and Fertility Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Blood Gas/Electrolytes Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Urinalysis Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.8 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Laboratory Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Point-of-Care Testing (POCT) Market Analysis and Outlook to 2028

    • 13.1 Global Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.2.2 Canada Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.3.2 UK Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.3.3 Spain Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.3.5 France Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.3.6 Italy Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.3.8 Finland Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.3.9 Norway Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.3.11 Poland Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.3.12 Russia Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.4.2 Japan Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.4.3 India Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.5.3 Chile Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.5.6 Peru Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.6.3 Oman Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Point-of-Care Testing (POCT) Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Point-of-Care Testing (POCT)

    • Figure of Point-of-Care Testing (POCT) Picture

    • Table Global Point-of-Care Testing (POCT) Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Point-of-Care Testing (POCT) Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Blood Glucose Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Diseases Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiac Markers Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Coagulation Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Pregnancy and Fertility Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Gas/Electrolytes Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Urinalysis Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Laboratory Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Point-of-Care Testing (POCT) Consumption by Country (2017-2022)

    • Table North America Point-of-Care Testing (POCT) Consumption by Country (2017-2022)

    • Figure United States Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Canada Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Mexico Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Table Europe Point-of-Care Testing (POCT) Consumption by Country (2017-2022)

    • Figure Germany Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure UK Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Spain Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Belgium Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure France Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Italy Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Denmark Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Finland Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Norway Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Sweden Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Poland Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Russia Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Turkey Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Table APAC Point-of-Care Testing (POCT) Consumption by Country (2017-2022)

    • Figure China Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Japan Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure India Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Thailand Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Singapore Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Philippines Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Table South America Point-of-Care Testing (POCT) Consumption by Country (2017-2022)

    • Figure Brazil Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Colombia Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Chile Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Argentina Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Peru Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Table GCC Point-of-Care Testing (POCT) Consumption by Country (2017-2022)

    • Figure Bahrain Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Oman Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Qatar Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Table Africa Point-of-Care Testing (POCT) Consumption by Country (2017-2022)

    • Figure Nigeria Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure South Africa Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Egypt Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure Algeria Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Table Oceania Point-of-Care Testing (POCT) Consumption by Country (2017-2022)

    • Figure Australia Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Point-of-Care Testing (POCT) Consumption and Growth Rate (2017-2022)

    • Table Ascensia Company Details

    • Table Ascensia Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ascensia Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table Ascensia Point-of-Care Testing (POCT) Product Portfolio

    • Table Bio-Rad Laboratories Company Details

    • Table Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Rad Laboratories Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio

    • Table Siemens Healthcare Company Details

    • Table Siemens Healthcare Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthcare Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio

    • Table Danaher Company Details

    • Table Danaher Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Danaher Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table Danaher Point-of-Care Testing (POCT) Product Portfolio

    • Table Quidel Company Details

    • Table Quidel Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Quidel Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table Quidel Point-of-Care Testing (POCT) Product Portfolio

    • Table Nova Biomedical Company Details

    • Table Nova Biomedical Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nova Biomedical Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio

    • Table Abaxis (Zoetis) Company Details

    • Table Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abaxis (Zoetis) Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio

    • Table Helena Laboratories Company Details

    • Table Helena Laboratories Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Helena Laboratories Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio

    • Table Ortho Clinical Diagnostics Company Details

    • Table Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio

    • Table Phamatech Company Details

    • Table Phamatech Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Phamatech Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table Phamatech Point-of-Care Testing (POCT) Product Portfolio

    • Table BioMerieux Company Details

    • Table BioMerieux Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioMerieux Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table BioMerieux Point-of-Care Testing (POCT) Product Portfolio

    • Table OraSure Technologies Company Details

    • Table OraSure Technologies Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table OraSure Technologies Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio

    • Table Alfa Wassermann Company Details

    • Table Alfa Wassermann Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alfa Wassermann Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio

    • Table ARKRAY Company Details

    • Table ARKRAY Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table ARKRAY Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table ARKRAY Point-of-Care Testing (POCT) Product Portfolio

    • Table A Menarini Diagnostics Company Details

    • Table A Menarini Diagnostics Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table A Menarini Diagnostics Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table A Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio

    • Table ELITech Group Company Details

    • Table ELITech Group Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table ELITech Group Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table ELITech Group Point-of-Care Testing (POCT) Product Portfolio

    • Table Trinity Biotech Company Details

    • Table Trinity Biotech Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Trinity Biotech Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio

    • Table Chembio Diagnostics Company Details

    • Table Chembio Diagnostics Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chembio Diagnostics Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio

    • Table Princeton BioMeditech Company Details

    • Table Princeton BioMeditech Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Princeton BioMeditech Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio

    • Table Trividia Health Company Details

    • Table Trividia Health Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Trividia Health Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table Trividia Health Point-of-Care Testing (POCT) Product Portfolio

    • Table Roche Company Details

    • Table Roche Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table Roche Point-of-Care Testing (POCT) Product Portfolio

    • Table Abbott Company Details

    • Table Abbott Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table Abbott Point-of-Care Testing (POCT) Product Portfolio

    • Table Response Biomedical Company Details

    • Table Response Biomedical Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Response Biomedical Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table Response Biomedical Point-of-Care Testing (POCT) Product Portfolio

    • Table Accriva Company Details

    • Table Accriva Point-of-Care Testing (POCT) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Accriva Point-of-Care Testing (POCT) Main Business and Markets Served

    • Table Accriva Point-of-Care Testing (POCT) Product Portfolio

    • Figure Global Blood Glucose Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious Diseases Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiac Markers Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Coagulation Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pregnancy and Fertility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Gas/Electrolytes Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Urinalysis Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Laboratory Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Point-of-Care Testing (POCT) Consumption Forecast by Country (2022-2028)

    • Table North America Point-of-Care Testing (POCT) Consumption Forecast by Country (2022-2028)

    • Figure United States Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Point-of-Care Testing (POCT) Consumption Forecast by Country (2022-2028)

    • Figure Germany Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Point-of-Care Testing (POCT) Consumption Forecast by Country (2022-2028)

    • Figure China Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Point-of-Care Testing (POCT) Consumption Forecast by Country (2022-2028)

    • Figure Brazil Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Point-of-Care Testing (POCT) Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Point-of-Care Testing (POCT) Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Point-of-Care Testing (POCT) Consumption Forecast by Country (2022-2028)

    • Figure Australia Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Point-of-Care Testing (POCT) Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.